According to the WPATH, it is recommended that transfeminine people undergo estrogen hormone therapy a minimum of 12 months prior to breast augmentation surgery. The purpose is to maximize breast growth to obtain better surgical (aesthetic) results.
It’s important to note that this is not an explicit criterium but a strongly recommended suggestion that most doctors and private insurance companies follow.